|
|
| Line 1: |
Line 1: |
| [[File:Gerovital.jpg|thumb|250px|Original presentation of Gerovital]]
| | {{Short description|A controversial anti-aging treatment}} |
| '''Gerovital H3''' (or '''procaine hydrochloride''' and products known as GH3 and other variants which may or may not be identical to Gerovital H3) is a controversial preparation developed during the 1950s and falsely promoted by its advocates as an effective anti-aging treatment. In the United States, the FDA bans Gerovital H3 from interstate commerce as an unapproved drug and, since 1982, has prohibited its importation.
| |
|
| |
|
| Gerovital is promoted with false claims of its curative abilities for a wide range of human ailments; research has found no evidence that it has any health benefit or "antiaging" properties.<ref name=Perls/> | | '''Gerovital''', also known as '''GH3''', is a formulation developed in the mid-20th century by the Romanian scientist [[Ana Aslan]]. It is primarily known for its purported anti-aging properties and has been the subject of both interest and controversy in the medical community. |
|
| |
|
| ==Development and marketing== | | ==History== |
| The impetus for developing the drug is sometimes alleged to have come from [[Nicolae Ceaușescu]], who funded the establishment of a research organization, the National Institute of Geriatrics, in [[Bucharest]], [[Romania]], headed by [[Ana Aslan]] (1897–1988).<ref name=Perls/>
| | Gerovital was developed in the 1950s by [[Ana Aslan]], a Romanian physician and biologist. Aslan was a pioneer in the field of gerontology, the study of aging and its effects. She believed that Gerovital could slow down the aging process and improve the quality of life for the elderly. The formulation gained popularity in Romania and other parts of Europe, attracting attention from celebrities and political figures. |
|
| |
|
| From the 1950s until her death in 1988, Aslan promoted Gerovital H3 with great success. In the 1960s and 1970s her Romanian clinic, the Parhon Institute, became a mecca for celebrities seeking treatment, and an upscale tourist attraction. ''The New York Times'' referred to Gerovital's "jet-set aura," noting that Aslan had been covered in "society columns where such public figures as [[Nikita S. Khrushchev]], [[Konrad Adenauer]], and [[Ibn Saud]] have been listed among the multitudes said to have taken the drug." As late as 1988 an advertisement by the Romanian National Tourist Office lauded "the picturesque and exciting cities, scenic delights, famous resorts (including Gerovital H3 treatment centers), cultural and historic treasures that await the traveler to Romania."<ref>{{cite news| title=Our colorful TOUROMANIA booklet has it all | publisher=New York Times | date=1988-03-06}}</ref>
| | ==Composition== |
| | Gerovital is based on the compound [[procaine]], a local anesthetic. The formulation includes procaine hydrochloride, along with other ingredients such as benzoic acid and potassium metabisulfite. The exact mechanism by which Gerovital is claimed to exert its effects is not well understood, but it is believed to involve the stabilization of cell membranes and the improvement of cellular metabolism. |
|
| |
|
| With the rise of the [[World-wide web|Web]] Gerovital has enjoyed a new lease of promotional life as it is promoted by many sites with claims of its "cure-all" abilities.<ref name=Perls/>
| | ==Claims and Uses== |
| | Proponents of Gerovital claim that it can reduce the effects of aging, improve mental clarity, and enhance overall vitality. It has been marketed as a treatment for a variety of conditions, including [[arthritis]], [[depression]], and [[hypertension]]. However, these claims are largely anecdotal, and scientific evidence supporting the efficacy of Gerovital is limited. |
|
| |
|
| ==Denouncement== | | ==Controversy== |
| A 1973 ''[[New York Times]]'' article said "cold water was thrown on [Gerovital]'s reputation years ago" by "three reports published simultaneously in British Medical Journal [that said it] found no merit for procaine hydrochloride for any of the problems of aging."<ref>{{cite news| title=Disputed Drug Is Restudied for Use in Geriatrics | publisher=New York Times | date=1973-03-18 | author=Harold M. Schmeck Jr}}</ref>
| | The use of Gerovital has been controversial, particularly in the [[United States]] and other countries where it is not approved by regulatory agencies such as the [[Food and Drug Administration]] (FDA). Critics argue that there is insufficient scientific evidence to support the claims made about Gerovital, and concerns have been raised about its safety and potential side effects. |
|
| |
|
| Some clinical trials in the mid-to-late 1970s suggested that Gerovital H3 acts as a weak, competitive, reversible [[Monoamine oxidase inhibitor|MAO inhibitor]], and so may have some antidepressant value, but otherwise has negligible effect on disease. In 1994, the U.S. [[Food and Drug Administration|FDA]] Consumer magazine said: "No health claims for Gerovital have been substantiated, and FDA considers it an unapproved new drug. It has caused low blood pressure, respiratory difficulties, and convulsions in some users."<ref>{{cite news |url=http://www.fda.gov/bbs/topics/CONSUMER/CON00275.html |title=Unproven Medical Treatments Lure Elderly |publisher=FDA Consumer Magazine |date=March 1994 |author=Jed Disbennett |url-status=dead |archiveurl=https://web.archive.org/web/20041211084928/http://www.fda.gov/bbs/topics/CONSUMER/CON00275.html |archivedate=2004-12-11 }}</ref> Suppliers assert that the product is safe, and one cites a brief quotation from a newspaper article that says "while as early as 1973 Elmer Gardner of the FDA's Bureau of Drugs stated 'There is no safety problem with Gerovital H-3.'"<ref>{{cite web | url=http://www.realgh3.com/quotes.html | title=FDA Quotes | publisher=Tierra Mega-Nutrients | accessdate=2006-11-28 |archiveurl = https://web.archive.org/web/20060620065731/http://realgh3.com/quotes.html |archivedate = 2006-06-20}}</ref>
| | ==Current Status== |
| | Despite the controversy, Gerovital continues to be used in some countries, particularly in [[Eastern Europe]]. It is available in various forms, including injections, tablets, and creams. In recent years, interest in Gerovital has waned as more advanced and scientifically validated anti-aging treatments have become available. |
|
| |
|
| ==Effectiveness== | | ==Related pages== |
| There is no evidence that Gerovital is helpful in slowing aging or treating illness.<ref name=Perls>{{cite journal |author=Perls T |title=The reappearance of procaine hydrochloride (Gerovital H3) for antiaging |journal=J Am Geriatr Soc |volume=61 |issue=6 |pages=1024–5 |date=June 2013 |pmid=23772727 |doi=10.1111/jgs.12278 |url=}}</ref>
| | * [[Ana Aslan]] |
| | * [[Procaine]] |
| | * [[Anti-aging]] |
| | * [[Gerontology]] |
|
| |
|
| ==Drug or nutrient?==
| |
| Procaine itself is often considered to be a drug. Earlier references by advocates of Gerovital H3 refer to it as a drug. Hoffer and Walker (1980) call it a "youth drug." Mircea Dumitru, Aslan's colleague and personal physician, describes it as "a complex drug acting like the procaine molecule ... The addition of benzoic acid, potassium and disodium phosphate increase the effects of Gerovital-H3 biotrophic treatment."<ref>{{cite web|first=Mircea |last=Dumitru M.D. Ph. D. |url=http://www.antiaging-systems.com/extract/geroh3.htm |title=Professor Ana Aslan and Gerovital-H3, the Original and First Anti-Aging Medicine |publisher=International Antiaging Systems |accessdate=2006-12-02 |url-status=dead |archiveurl=https://web.archive.org/web/20060518164154/http://www.antiaging-systems.com/extract/geroh3.htm |archivedate=2006-05-18 }}</ref>
| |
|
| |
| ==FDA ban==
| |
| {{As of|2004}}, the FDA's 1982 automatic detention alert is still in effect and bans the import of Gerovital H3 into the U.S. as "a new drug within the meaning of 201(p), without an approved new drug application [Unapproved New Drug, Section 505(a)]."<ref>{{cite web|url=http://www.fda.gov/ora/fiars/ora_import_ia6101.html |title=Automatic Detention [for Gerovital] (IA#61-01) |publisher=U.S. Food and Drug Administration |accessdate=2006-11-28 |archiveurl=https://web.archive.org/web/20060930123927/http://www.fda.gov/ora/fiars/ora_import_ia6101.html |archivedate=2006-09-30 |url-status=dead }}</ref>
| |
|
| |
| The ban covers:
| |
| *Gerovital, GH3, KH3, Zell H3, GH3 etc. This order was rescinded for GEROVITAL Cosmetics Lines, not containing procaine.
| |
| *finished injectable or oral Procaine Hydrochloride
| |
|
| |
| ==References==
| |
| {{Reflist}}
| |
|
| |
| [[Category:Ageing]]
| |
| [[Category:Alternative medicine]]
| |
| [[Category:Health fraud]]
| |
| [[Category:Withdrawn drugs]]
| |
| [[Category:Patent medicines]]
| |
| [[Category:Anti-aging substances]] | | [[Category:Anti-aging substances]] |
| [[Category:Romanian inventions]] | | [[Category:Romanian inventions]] |
| | [[Category:Controversies in medicine]] |
A controversial anti-aging treatment
Gerovital, also known as GH3, is a formulation developed in the mid-20th century by the Romanian scientist Ana Aslan. It is primarily known for its purported anti-aging properties and has been the subject of both interest and controversy in the medical community.
History[edit]
Gerovital was developed in the 1950s by Ana Aslan, a Romanian physician and biologist. Aslan was a pioneer in the field of gerontology, the study of aging and its effects. She believed that Gerovital could slow down the aging process and improve the quality of life for the elderly. The formulation gained popularity in Romania and other parts of Europe, attracting attention from celebrities and political figures.
Composition[edit]
Gerovital is based on the compound procaine, a local anesthetic. The formulation includes procaine hydrochloride, along with other ingredients such as benzoic acid and potassium metabisulfite. The exact mechanism by which Gerovital is claimed to exert its effects is not well understood, but it is believed to involve the stabilization of cell membranes and the improvement of cellular metabolism.
Claims and Uses[edit]
Proponents of Gerovital claim that it can reduce the effects of aging, improve mental clarity, and enhance overall vitality. It has been marketed as a treatment for a variety of conditions, including arthritis, depression, and hypertension. However, these claims are largely anecdotal, and scientific evidence supporting the efficacy of Gerovital is limited.
Controversy[edit]
The use of Gerovital has been controversial, particularly in the United States and other countries where it is not approved by regulatory agencies such as the Food and Drug Administration (FDA). Critics argue that there is insufficient scientific evidence to support the claims made about Gerovital, and concerns have been raised about its safety and potential side effects.
Current Status[edit]
Despite the controversy, Gerovital continues to be used in some countries, particularly in Eastern Europe. It is available in various forms, including injections, tablets, and creams. In recent years, interest in Gerovital has waned as more advanced and scientifically validated anti-aging treatments have become available.
Related pages[edit]
